Beckman Coulter Life Sciences, a Danaher company and a global leader in laboratory automation and innovation, announces the launch of its new IR820 and IR870 infrared dye antibody conjugates. For the first time, research flow cytometry labs have a low noise solution, including single laser excitation, no dye interferences along with negligible overlap with other fluorochrome emissions, and ultralow autofluorescence background...

Beckman Coulter Life Sciences, a Danaher company and a global leader in laboratory automation and innovation, announces the launch of the OptiMATE Gradient Maker, a groundbreaking instrument designed to automate the process of density gradient ultracentrifugation (DGUC). The new system accelerates purification processes by up to 75% while improving consistency and reproducibility...

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, and an Operating Company of Danaher Corporation, revolutionizes spectral flow cytometry with the industry’s first modular solution:  the CytoFLEX mosaic Spectral Detection Module. When connected to the CytoFLEX LX or S Flow Cytometers, the CytoFLEX mosaic Spectral Detection Module delivers superior fluorescence sensitivity for dim and complex multicolor experiments and can detect nanoparticles as small as 80 nm...

Beckman Coulter Diagnostics, a clinical diagnostics leader, has announced that the new DxC 500i Clinical Analyzer, an integrated clinical chemistry and immunoassay analyzer, received 510(k) clearance from the U.S. Food and Drug Administration. The DxC 500i combines advanced technology with an intuitive user interface, ensuring that laboratories of all sizes can meet the growing demands of modern healthcare...

New Partnership Expands Oncology Research Possibilities. Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, in partnership with Rarity Bioscience AB offers a new approach to oncology research by extending the capabilities of flow cytometry to clinical molecular research. Under a co-exclusive distribution agreement between the two companies, Beckman Coulter Life Sciences will market and distribute the Rarity Bioscience AB superRCA® technology assays...

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, and a company of Danaher Corporation (NYSE: DHR), launches the Cydem VT Automated Clone Screening System, a revolutionary high-throughput microbioreactor platform for automated top clone screening. The new Cydem VT System significantly reduces time to market for biologic drug discovery and monoclonal antibody-based therapeutics, by slashing manual laboratory steps in Cell Line Development up to 90%...

10x Genomics, Inc., a leader in single cell and spatial biology, and Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, have announced the commercial availability of a new solution to automate single cell gene expression workflows. The new offering, which includes an automation-friendly library preparation kit from 10x Genomics and an optimized method from Beckman Coulter Life Sciences...

Assay Automation Makes Cutting-Edge Research More Accessible to Labs. Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, in partnership with Illumina, a leader in DNA sequencing and array-based technologies, offers a promising new approach to oncology research delivering faster results with fewer touchpoints...

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, accelerates high-throughput genomic sample preparation workflows to deliver results faster with the launch of its Biomek Echo One System. The new solution provides versatile integrated acoustic liquid handling options for applications in genomic workflows, including high-throughput isothermal DNA assemblies and NGS library sample preparations...

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, continues its mission to reduce workflow times and grueling manual steps with the launch of its new Valita Aggregation Pure assay. The plate-based 96-well screening tool offers rapid, high-throughput protein aggregation detection and quantification, providing robust aggregation data in as little as 15 minutes...

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, has entered a collaborative partnership with Watchmaker Genomics, an expert in genomics tools development for high-stringency clinical and translational applications. The partnership harnesses the value of each organization to deliver robust and reliable automated liquid handling solutions that enable labs to streamline operations and generate consistent results...

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, makes pharmaceutical and biopharmaceutical analysis faster and simpler with more robust data in the launch of the QbD1200+ Total Organic Carbon (TOC) Analyzer. Offering simplified validation and reporting on encrypted data, it is designed to support 21 CFR Part 11 requirements and major global pharmacopeia regulations: USP, EP, JP, IP, KP....

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation and a subsidiary of Danaher Corporation continues to lead the way with first-to-market concepts with the launch of the CytoFLEX nano Flow Cytometer – the first purpose-built nanoscale flow cytometer for research use only that enables detection to at least 40 nm,* enabling 30-50% more data creation compared to current marketplace offerings...

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, has received 510(k) clearance from the Food and Drug Administration (FDA) to distribute its DxFLEX Clinical Flow Cytometer in the United States. Launched regionally in 2020, this advancement brings the popular benchtop IVD flow cytometry system to American labs while expanding testing capabilities. Offering up to 13-colors, additional detectors can be activated as laboratory needs evolve without the need to purchase additional hardware...

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, announces a strategic partnership with Polycarbin, a pioneer in sustainable laboratory solutions, to drive a paradigm shift in lab sustainability for liquid handling automation plastics This collaboration combines the extensive experience of Beckman Coulter Life Sciences in automated liquid handling with Polycarbin’s sustainability-focused circular economy platform for laboratory plastics.

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, continues to lead the way with first-to-market concepts to help laboratories achieve goals faster and with greater accuracy. The company announces it has developed the first commercially available anti-TRBC2 conjugated antibody for flow cytometry, providing greater clarity to clinical researchers in the identification of T-cell neoplasms in areas including cancer research...

Innovation Provides United States with First Workflow Update in 25 Years. Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, has received 510(k) clearance from the Food and Drug Administration (FDA) to distribute its popular AQUIOS STEM System in the United States. This innovation provides labs with an evolution of the gold standard for hematopoietic stem cell enumeration...

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, and 10x Genomics, Inc., a leader in single cell and spatial biology, today announced a new partnership to expand automation solutions for single cell assay workflows. As part of the agreement, 10x Genomics plans to develop dedicated Chromium Single Cell kits to be used on a Biomek i7 Automated Liquid Handler by Beckman Coulter Life Sciences...

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, is lighting up microbioreactor research with its powerful new Light Array Module (LAM) for the popular BioLector XT Microbioreactor. For the first time, this new advancement enables work with light-dependent organisms that need to perform photosynthesis to grow...

Beckman Coulter, a clinical diagnostics leader, has unveiled the DxI 9000 Access Immunoassay Analyzer, the most productive immunoassay analyzer per footprint. The DxI 9000 Analyzer can run up to 215 tests per hour per square meter (tests/hr/m2). The DxI 9000 Analyzer innovations address today’s speed, reliability, reproducibility, quality, and menu expansion demands...

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, is leading the way to help laboratories prepare for critical upgrades to comply with the new In Vitro Diagnostic Medical Devices Regulation (IVDR), and to clear up confusion for laboratories that will soon be governed by IVDR. A special resource guide has been created to assist labs at all stages of the IVDR marathon and includes eBooks, whitepapers, and Frequently Asked Questions...

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, will have a full team of dedicated professionals and informative programming at the upcoming Society for Laboratory Automation and Screening (SLAS) International Conference and Exhibition. The show will take place February 25 – March 1, 2023, at the San Diego Convention Center...

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, further strengthens its commitment to the greater Loveland, Colorado community with the completion of the first phase of its new research and development hub. The grand opening of the new $10 million office complex will house its growing workforce in the Axis 25 Development at 4510 Byrd Drive near the Northern Colorado Regional Airport...

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, introduces an automated solution for the grueling and time-consuming process of manual gating flow cytometry data, with no programming skills required. This revolutionary feature is part of the new Cytobank v10 platform upgrade which is available now. An Automated Gating Workflow can shorten hands-on time by up to 75%...

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, announces its continuing commitment to the next generation of researchers and scientists with a call for registrations for its SPRI Grants for Genomic Research. Reinforcing its dedication to providing streamlined genomic workflow solutions, the company will award up to eight grants in 2022...

Cell sorting is complex but your sorter doesn't have to be. With the flexibility to output in a variety of plate and tube formats, an easy-to-clean and easy-to-exchange nozzle, and the ability to sort four populations simultaneously, the CytoFLEX SRT cell sorter gives you powerful, flexible sorting in a compact footprint. And when paired with a CytoFLEX flow cytometer, you’ll create a seamless detection and sorting experience where parameter-matched templates can be converted in a few clicks to sort experiment...

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, announces it has acquired ValitaCell Ltd. (“ValitaCell”), a biotechnology company that creates pioneering analytical products and technologies for the biopharmaceutical industry. Headquartered in Dublin, Ireland, ValitaCell creates analytical technologies and products for the biopharmaceutical industry with the goal of reducing new therapeutics' cost and time to market...

Beckman Coulter Life Sciences, a global leader in laboratory automation and biotechnology innovation, announces a partnership with Flownamics to create an automated, on-line solution for bioprocess culture monitoring and control. This delivers a critical and practical update to the significant unmet need for automated, real-time cell analysis in the current bioprocessing environment....

Beckman Coulter, a global clinical diagnostics leader, announces a new partnership with Germany-based company Smart4Diagnostics to close the preanalytical data gap between blood collection and laboratory analysis due to errors that take place before the sample arrives in the laboratory, such as sample collection, patient identification, sample handling, sample transportation, sample loss, etc.

Beckman Coulter Life Sciences, a global leader in laboratory workflow automation and innovation, and a company of Danaher Corporation (NYSE: DHR), unleashes the power of next generation sequencing and makes it more accessible for research labs of all sizes with the launch of the Biomek NGeniuS liquid handling system. The compact instrument automates the labor-intensive process of manual library construction and reagent transfers, helping free up technicians and researchers to focus on the science...

Leading the way since 1947 with automation and innovation in centrifugation, Beckman Coulter Life Sciences announces a series of events to celebrate its 75th anniversary. Highlights include the launch of the Allegra V-15R Benchtop Centrifuge, along with the industry’s highest-volume vertical rotor – the VTi 50.1 – and a contest to find the oldest centrifuge produced by the company...

New Innovation Significantly Reduces Turnaround Time While Decreasing Manual and Error-Prone Steps. Creating the industry’s first stem cell analysis update in nearly 25 years, Beckman Coulter Life Sciences – a global leader in laboratory automation and innovation – launches an evolution of the gold standard in hematopoietic stem cell enumeration, the AQUIOS STEM System...

Companies around the world continue to show strong interest in the Biomek NGeniuS Next Generation Library Prep System from Beckman Coulter Life Sciences and seek to develop demonstrated applications on this easy-to-use new NGS automation platform, which reduces errors and minimizes hands-on time. Following a successful unveiling to the media and lab researchers at last month’s Society for Laboratory Automation and Screening (SLAS) International Conference & Exhibition in Boston, the company announces...

Beckman Coulter Life Sciences continues to work with chemistry companies seeking collaborations to develop applications for the Biomek NGeniuS Next Generation Library Preparation System ahead of its launch. An application development agreement has been signed with Illumina, a developer of solutions for the sequencing and analysis of genomes, to develop new applications on the Biomek NGeniuS System...

Beckman Coulter has announced the European launch of the DxU Iris Workcell, a fully-automated system that streamlines urinalysis workflow and reduces manual microscopy. A routine urinalysis is one of the most frequently-ordered tests, representing up to 30% of all samples received in the lab. Many of these samples require a lab technician to perform manual inspection, resulting in workflow disruption and increase in workload...

Beckman Coulter, a global leader in diagnostics and infertility testing, announce the launch of an AMH test that uses a validated cut-off to aid in the assessment of poor ovarian response. This new assay helps clinicians predict poor ovarian response in those who plan to undergo controlled ovarian stimulation as part of an in vitro fertilisation (IVF) protocol[i]. The AMH Advanced assay is available in European countries that accept the CE marking....

Labs processing 2,000 to 5,000 tests a day can finally enjoy the benefits of Total Laboratory Automation (TLA) with a compact workflow-automation solution that fits needs. Beckman Coulter, a clinical diagnostics leader, has announced the European launch of the DxA 5000 Fit, a workflow-automation solution designed to fit into medium-sized labs that run fewer than 5,000 tests a day...

Beckman Coulter has announced that it has expanded claims for its CE-marked Access Interleukin-6 (IL-6) assay. The Access IL-6 assay is an in-vitro diagnostic test for the quantitative determination of IL-6 levels in human serum and plasma (heparin). The fully-automated assay helps physicians identify a severe inflammatory response in COVID-19 patients, often referred to as cytokine storm, and determine the risk of intubation with mechanical ventilation, in conjunction with clinical findings and the results of other laboratory testing....

Beckman Coulter, a global leader in clinical diagnostics, announce the launch of the DxH 560 AL, a tabletop analyser geared to reduce the time and resource constraints faced by small to mid-sized laboratories. With the analyser’s Auto-Loading functionality, closed tube aspiration and walkaway capabilities, users can continually add up to 50 samples, provide safety against blood-borne pathogens and spend less time on manual instrument tasks....

Beckman Coulter, a clinical diagnostics leader, today launched its Access SARS-CoV-2 IgG II assay in countries accepting the CE Mark. The new Access SARS-CoV-2 IgG II assay quantitatively measures a patient’s level of antibodies in response to a previous SARS-CoV-2 infection. The ability to establish a quantitative baseline to evaluate an individual’s immune response to the SARS-CoV-2 virus allows clinicians to assess relative changes of an individual’s immune response to the virus over time based on a numerical value....

The new IgM antibody test demonstrated 99.9% specificity with 1,400 negative samples and 100% sensitivity at >18 days post symptom onset and post positive PCR. Beckman Coulter’s IgM assay is part of a full suite of testing solutions the company is developing to inform clinical and public health decision making during the COVID-19 pandemic. Beckman Coulter is also developing a SARS-CoV-2 antigen test and quantitative IgG assay....

Beckman Coulter, a clinical diagnostics leader, has announced its Access SARS-CoV-2 Immunoglobulin M (IgM) assay has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA). The assay detects antibodies that recognize the receptor binding domain (RBD) of the spike protein which the SARS-CoV-2 virus uses to enter the human host cells. The assay, which demonstrates 99.9% specificity and 98.3% sensitivity, is part of a suite of diagnostic solutions....

Beckman Coulter has announced that it has received Emergency Use Authorization (EUA) for its Access Interleukin-6 (IL-6) assay from the U.S. Food & Drug Administration (FDA). Access IL-6 is a fully automated immunoassay designed to detect IL-6 levels in serum and plasma which can be used to aid physicians identifying a severe inflammatory response and determining the risk of intubation with mechanical ventilation in COVID-19 patients...

Beckman Coulter has announced that its Access SARS-CoV-2 IgG assay has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration (FDA). Beckman Coulter has already shipped tests to more than 400 hospitals, clinics and diagnostics laboratories in the U.S., and has begun distribution of the new antibody test globally to countries that accept the FDA EUA and CE Mark. The company is able to deliver more than 30 million tests a month...

The sensitivity of Beckman Coulter Life Sciences’ CytoFLEX Flow Cytometer is underpinning a pioneering multinational research initiative. This is designed to transform the lives of those suffering from a disfiguring and potentially life threatening parasitic disease. The research team has just secured a grant of eight million Euros from the European & Developing Countries Clinical Trials Partnership...

New IgM and IgG antibody assays will help indicate whether a person potentially developed immunity against the coronavirus (SARS-CoV-2) In response to the global COVID-19 pandemic, Beckman Coulter announce that it is developing assays to identify IgM and IgG antibodies to the coronavirus or SARS-CoV-2. The assays will be designed for use on any of its high- throughput Access family of immunoassay systems...

Beckman Coulter, a global leader in clinical diagnostics, will debut its recently announced DxA 5000 total laboratory automations solution in booth 188 at the 23rd IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine (EuroMedLab) conference in Barcelona, Spain 19-23 May 2019. The DxA 5000 will take center stage at the booth, and will be complemented by a host....

A major milestone on its strategic mission to lead in sepsis diagnostics, Beckman Coulter has announced that its Early Sepsis Indicator has received 510(k) clearance from the U.S. Food and Drug Administration. Sepsis is a global healthcare crisis that affects more than 30 million people worldwide.1 The Early Sepsis Indicator is a first-of-its-kind, hematology-based cellular...

The DxA 5000 supports laboratories in delivering highly consistent turnaround time to their physicians. Leveraging first-of-its-kind dynamic system software, the DxA 5000 utilizes Intelligent Routing to bring automated patient-centric workflow to the laboratory. By understanding the tests requested, sample volume available and real-time analyzer capacity and status, the DxA 5000 continuously calculates the most expeditious route for every patient sample—both STAT and routine....

The cost-effective, cloud-based middleware solution helps low-volume laboratories streamline processes and minimize costs. Beckman Coulter has announced the U.S. release of its DxONE Workflow Manager, the first and only cloud-based middleware offered by a major in-vitro diagnostics organization, designed to help low-volume laboratories deliver timely results for patient care by enhancing consistency, accuracy and efficiency....

Cloud-based solution streamlines labor-intensive inventory management tasks to improve resource management. Beckman Coulter announced the commercialization of DxONE Inventory Manager, its automated, cloud-based software technology that simplifies inventory management and enhances operational efficiencies to help ensure timely delivery of patient test results. With DxONE Inventory Manager, technologists gain an...

Collaboration unites a worldwide leader in the clinical diagnostics industry with one of the nation’s top research and healthcare institutions to ideate solutions that will address today’s healthcare challenges. Beckman Coulter Diagnostics, a global leader in the clinical diagnostics industry, is embarking on an innovation collaboration with Johns Hopkins Medicine to explore co-innovation initiatives with the goal of developing and commercializing novel solutions that address challenges in healthcare....

Beckman Coulter Life Sciences has launched the next-generation laser diffraction particle analyzer, the LS 13 320 XR − to meet the exacting demands of quality control and research applications in pharmaceutical and industrial sectors. The LS 13 320 XR delivers fast, accurate and reproducible high-resolution measurement and analysis, eliminating complex procedure setups and reducing the time required to process liquid or dry samples....

Provides the smooth sample-handling of an ultracentrifuge from a space-saving benchtop model

Celebrating 70 years as a world leading manufacturer of laboratory centrifuges, Beckman Coulter Life Sciences introduces the next generation of refrigerated, high-speed benchtops—the Avanti J-15 Series. Designed to leverage harmonic technology that ensures ultra-smooth acceleration/deceleration profiles....

First Standard Configuration Analyzer to Offer Ultraviolet and Infrared Lasers with Avalanche Photodiode Detectors

Beckman Coulter Life Sciences has opened up the possibilities for cancer researchers with the launch of the first flow cytometer to offer excitation sources across the visible spectrum in a standard configuration.....

Platform Offers up to Six Lasers, 21 Colors for Multiparametric Analysis with Nanoparticle Detection

Beckman Coulter Life Sciences continues to expand the multi-parameter capabilities of its patented CytoFLEX flow cytometer technology.  Its latest model, the CytoFLEX LX, with up to six lasers and 21 fluorescent channels, delivers even more parameters with the same exceptional fluorescence sensitivity and superior nanoparticle detection demanded by high end researchers....

Next-Generation Liquid Handling Platform Designed to Meet Evolving Workflow Priorities

Beckman Coulter Life Sciences re-emerges as an innovator in automated liquid handling solutions with the introduction of the Biomek i-Series Automated Workstations, at the 2017 international conference of the Society for Laboratory Automation and Screening in Washington D.C. “Beckman Coulter Life Sciences is renewing its commitment to innovation, our partners and our customers with the introduction of the Biomek i-Series Automated Workstations....

Enhances Quality Control with Early Detection of Miniscule Contaminants

Beckman Coulter Life Sciences is introducing the HIAC PODS+ Liquid Particle Counter, with advanced features for the early detection of minute contaminants. The portable PODS+ delivers fast, lab quality liquid contamination analysis in less than 60 seconds.  Its multi-liquid testing capability means it is suitable for heavy industrial environments such as...

Automated, walkaway solutions standardise and streamline the path to accurate therapeutic diagnoses, benefitting both laboratories and patients

Beckman Coulter has launched two automated systems in the UK to ease rapidly increasing workloads in microbiology and virology departments. The DxN VERIS Molecular Diagnostics system, for same-day molecular viral load testing, and the MicroScan Microbiology Systems for microorganism identification (ID) and antimicrobial susceptibility testing....

New simple-to-use 5-part diff DxH 500 ideal for wide-ranging applications

Beckman Coulter has installed the first DxH 500 haematology analyser in the UK at the University of Chester’s Institute of Medicine on the Countess of Chester Health Park. Ideal for use in hospitals, clinics, research and point–of-care, the newly launched DxH 500 fully automated haematology system will be used in post graduate clinical research projects...

Niguarda Hospital, Milan, shares experiences in newly available case study

A newly released case study, available from Beckman Coulter, describes the experiences of Niguarda Hospital’s Molecular Biology Laboratory in the assessment of the DxN VERIS Molecular Diagnostics System.  Involving fewer steps and reagents, and with true, single sample random access, DxN VERIS...

Beckman Coulter is pleased to highlight results published in the Journal of Clinical Virology that show the company DxN VERIS VERIS CMV Assay is more sensitive, and the DxN VERIS Molecular Diagnostics System has greater ease-of-use benefits, than another commercially available testing system.

Undertaken at the Department of Virology, Toulouse University Hospital, and the Department of Physiopathology, Toulouse Purpan, Unit Inserm U563, Toulouse, France, the study evaluated the analytical characteristics and performance of the fully automated DxN VERIS Molecular Diagnostics System in comparison to results obtained from the Roche COBAS^® Ampliprep™/COBAS^® TaqMan CMV test...

Beckman Coulter is pleased to highlight the findings of a poster, presented at ECCMID, Amsterdam, 2016, regarding the analytical performance of the company’s fully automated DxN VERIS Molecular Diagnostics System and VERIS HIV-1 Assay.

The European multi-centre study was undertaken at 10 centres in Germany, Spain, Italy, France and the UK.  All sites followed the same protocol provided by Beckman Coulter. Method comparisons were made between the Beckman DxN VERIS HIV-1 assay, and the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 v2.0 assay, the Abbott RealTime HIV-1 assay and the Siemens kPCR HIV-1 assay and were determined on...

Precision medicine requires success in two intertwined aspects: precision therapy and personalized medicine.

Precision therapy is being able to effectively treat the right disease; to have therapies that target for the correct pathological pathways.  Personalized medicine requires diagnosing a specific individual’s disease based on accurate assessment their complex health and pathological status. Our underlying premise is that an individual’s baseline proteome reflects their past and present and thus, will dictate their future health and...

Optima AUC Delivers Enhanced Optics and Improved Software to Open New Applications

Beckman Coulter Life Sciences is to launch the new Optima AUC at this year’s Analytica: 25th International Trade Fair for Laboratory Technology, Analysis, Biotechnology and analytica conference, being held in Munich, Germany, from May 10-13, 2016. This next generation analytical ultracentrifuge has been developed with many enhanced capabilities. The new Optima AUC is a fast, sophisticated and...

Findings from Sheffield Teaching Hospitals NHS Trust

Beckman Coulter today announced that the Sheffield Teaching Hospitals Virology Department is the first site to introduce the company’s DxN VERIS HBV assay* routinely.  Operating on the DxN VERIS Molecular Diagnostics System, that consolidates DNA extraction, amplification and detection within a single automated instrument, the HBV assay will allow the laboratory to offer service users greater precision at...

Niguarda Hospital case study now available

A case study describing the experiences of Niguarda Hospital, Milan, in assessing the new DxN VERIS Molecular Diagnostics System is now available from Beckman Coulter. The case study describes the workflow improvements and reduced turnaround times that the hospital’s Molecular Biology Laboratory was able to achieve for viral load measurements using the DxN VERIS system. One of Italy’s leading General Hospitals...

Sheffield Teaching Hospitals NHS Trust report ease of use

Beckman Coulter recently commissioned independent system performance trials of the new DxN VERIS Molecular Diagnostics System* and results show that the system is easy to operate with technicians fully operational on the system following just 20 minutes training. Following a trial undertaken at Sheffield Teaching Hospital NHS Trust, UK, Duncan Whittaker, Laboratory Manager Virology,stated “Training staff to use the DxN VERIS...

An internationally renowned gene therapy research team has won a $200,000 CytoFLEX Flow Cytometer from Beckman Coulter Life Sciences.

The contest was designed to explore innovative research solutions involving flow cytometry. The winning team, headed up by Dr Martin Pulé, is from UCL Cancer Institute at University College London, UK. Their submission focused on capitalizing on the power of multi-parameter flow cytometry to expand understanding of the molecular mechanisms of cancer at the single cell level. The CytoFLEX Flow Cytometer measures up to...

Beckman Coulter Diagnostics today launched its new website specifically for molecular diagnostics. 

The new site beckmancoulter.com/moleculardiagnostics has been designed not only to showcase the company’s DxN VERIS Molecular Diagnostics System* but also to provide quick and easy access to scientific resources and educational materials for the molecular diagnostics laboratory. “Our aim with the new site has been to make finding information about our molecular diagnostics products – both the DxN VERIS system and its...

Spanish study now available

Beckman Coulter Diagnostics today announced the availability of an independent case study, undertaken in Spain, that demonstrates that the company’s DxN VERIS  Molecular Diagnostics System* has the potential to improve productivity and turnaround times. The study, conducted by Nexus Global Solutions (Plano, Texas, USA) was undertaken with the assistance of Professor Jordi Vila, Head of Department of Clinical Microbiology...

Beckman Coulter Life Sciences and IncellDx, Inc. announced today they have signed a distribution agreement which focuses exclusively on clinical researchers in China, Hong Kong and Taiwan working on the Human Papilloma Virus (HPV) and cancer. 

The commercial partnership brings the power of multi-parameter flow cytometry to molecular testing, improving workflow while delivering sensitive and highly reliable cell identification. IncellDx’s next generation (3Dx) investigational molecular assay used to quantify HPV E6, E7 mRNA in single cells has been specially optimized to run on Beckman Coulter’s innovative CytoFLEX flow cytometry system.* The high throughput system instrument...

Beckman Coulter Diagnostics has today made available Issue 4 of its DxN VERIS Molecular Diagnostics Evidence Pack. 

Following presentation of eight new scientific posters at the European Society for Clinical Virology meeting in Edinburgh, Scotland (September 2015), the Evidence Pack has been updated and now contains more than 20 evaluation posters presented at key infectious disease meetings across Europe. “These independent evaluations of our DxN VERIS Molecular Diagnostics System and assays* will be of great interest to virology laboratories...

Unique System Proven to Improve Laboratory Workflow and Productivity at Sheffield Teaching Hospitals NHS Trust

Beckman Coulter is pleased to announce the results of recently commissioned independent trials of the new DxN VERIS Molecular Diagnostics System*  which showed enhanced workflow and productivity over incumbent systems. UK trial was undertaken within The Department of Virology at Sheffield Teaching Hospitals NHS Foundation Trust,  whose annual automated workload is approximately 105,000 serology samples...

New Instrument Helps Pharma Labs Comply with Global Quality Requirements

Beckman Coulter Life Sciences has launched the QbD1200 Total Organic Carbon (TOC) Analyzer.  Designed to be faster for higher TOC sample analysis throughput for the busy QC laboratory, the new instrument also carries out direct TOC analysis for greater quality and regulatory compliance. “The QbD1200 is designed to assist the pharmaceutical industry to meet the increasingly strict requirements of the major global regulatory* guidelines,” said...

Unique System Proven to Improve Laboratory Workflow and Productivity for Infectious Disease

Beckman Coulter Diagnostics is showcasing its DxN VERIS Molecular Diagnostics System* at the European Society for Clinical Virology (ESCV) meeting in Edinburgh, Scotland, 9-12 September 2015 on booth G5 where delegates can learn more about this new instrument that is set to revolutionise laboratory workflow. Recent evaluations undertaken in the UK and Spain have shown that DxN VERIS is simple to use (routine operator training taking approximately...

High Performance, Compact Flow Cytometry Instrument Delivers Full Analysis Capabilities  

Beckman Coulter Life Sciences is running a major competition for flow cytometry scientists, with the prize the recently launched CytoFLEX Flow Cytometer, valued at approximately 200,000 US dollars. Applicants are being asked to challenge the CytoFLEX Flow Cytometer to solve a key experimental puzzle for their research and to describe how it would deliver the solution, in 300 words or less. For more information visit: CytoFLEX Competition...

Beckman Coulter to use VNC as part of its life sciences and diagnostics products

19th January 2015: Beckman Coulter, a world leader in the IVD industry, and RealVNC™, the global provider of VNC® remote access technology today announced that Beckman Coulter will be licensing RealVNC’s technology for its support systems. VNC enables a computer user to remotely access another computer or device in a secure and reliable manner. Beckman Coulter will be deploying RealVNC’s top end solution, VNC with an Enterprise...

Flexible Forward Scatter Technology Enables Advances

MoFlo Astrios EQ, a six-way jet-in-air sorter from Beckman Coulter Life Sciences, delivers patent pending enhanced dual forward scatter (eFSC) technology for simultaneous sorting and detection of particles from 200 nm to 30 µm in diameter. The instrument sets a new standard for flow cytometry core facilities, delivering high-speed cell sorting and micro-particle detection in a single package. Featuring detailed and precise forward scatter resolution, beadless drop sample handling and increased biosafety, Astrios EQ meets a range of analysis needs...

Acquisition Will Broaden Product Offering, Provides Asian Operations Centre

Beckman Coulter Life Sciences has entered into an agreement to acquire Xitogen Technologies Inc. together with Cytojene Corporation. Xitogen, a flow cytometer developer based in Suzhou and Dalian, China, will provide Beckman Coulter Life Sciences with both a strong operational base in the growing China market and a high quality research instrument to round out their world-class cytometry offering. The acquisition is subject to customary closing conditions and is expected to close in the second quarter of 2014...

The JXN-26 Enhances Workflows in Research and Bioprocessing

High Performance Unit Supports Full Range of Common Tubes

Designed for applications that use common, disposable conical tubes, JA-14.50 rotors from Beckman Coulter Life Sciences extend the applications and flexibility of the company’s Avanti centrifuge series, and can be used inAvanti J-26S, J-30I and J-E centrifuges.  While greater capacity results in higher throughput, the rotors maintain the precision performance offered by products in the Avanti line and are the only high-performance rotors capable of spinning 50, 15, 5 and 1.5 mL conical tubes, and 50, 15 and 10 mL round bottom tubes and bottles at their maximum speeds...

Measure-Cells and Particles as Small as 02 Microns with the New-Multisizer 4e COULTER COUNTER

The latest Multisizer 4e features a new 10-micron aperture that enables users to obtain accurate count, size and mass distribution for particles and cells ranging from 0.2 to 1,600 microns.  Digital Pulse Processing provides high-resolution analysis in as many as 400 channels for unparalleled performance in pharmaceutical quality control, bioprocessing and industrial applications....

Transaction Expands Flow Cytometry Line, Targets Routine Clinical Analyses

Beckman Coulter Life Sciences, an innovator in life science research, has acquired the flow cytometry business assets of ReaMetrix India Pvt. Ltd, a Bangalore-based life science technology company. The transaction provides Beckman Coulter Life Sciences with temperature-stable, single-dose, multi-colour antibody cocktails targeting the HIV monitoring and clinical research markets. ReaMetrix products complement the company’s flow cytometry portfolio with reagents that will simplify the sample preparation process and provide highly standardized reagent combinations to cytometry laboratories around the globe...

Products Accelerate Fixation, Permeabilisation, Improve Signalling Detection

PerFix-Expose and PerFix-nc, innovative new reagent kits for intracellular staining from Beckman Coulter Life Sciences, minimize sample manipulation for a streamlined workflow that delivers high quality results. Developed for use on Beckman Coulter’s Gallios and Navios series flow cytometers and compatible with all Beckman Coulter Life Sciences’ fluorochromes, the kits enable a clear focus on the cytoplasmic and nuclear compartments of the cell...

From Protein Preparation to Sedimentation in a Small Footprint

Microfuge 20 and 20R microcentrifuges from Beckman Coulter Life Sciences are designed to meet the specific requirements of a wide range of research applications, and are efficient and easy to use. Paired with Microfuge series rotors, the compact instruments provide flexibility and reliable, precise performance while occupying a small footprint. Processes are performed seamlessly, and include nucleic acid and protein preparation; pelleting, extractions, purifications, concentrations, phase separations and receptor binding; and rapid sedimentation of protein precipitates, particulates and cell debris...

Leading US University (Center for Genomics and Bioinformatics, Indiana) Contributes to Collaboration

Beckman Coulter Life Sciences, through a partnership with Illumina, offers automated methods to improve processes and throughput in next generation sequencing (NGS) sample preparation. Under the agreement, Beckman Coulter will use its extensive experience in automated NGS sample preparation to develop, distribute and support automation for Illumina’s TruSeq^® and Nextera^® sample preparation kits and Illumina will provide technical expertise on chemistry and protocols....

HiSeq and Biomek platforms support a complete RNA-Seq solution

High throughput end-to-end RNA-Seq Service from Beckman Coulter Genomics includes customized project design, automated Illumina* TruSeq* RNA-Seq library construction and flexible, multiplexed sequencing on the Illumina HiSeq platform.  Downstream bioinformatics analysis options include primary data analysis, differential gene expression, splice variant analysis, gene fusion identi?cation and rare transcript identi?cation...

Speed and Precision Increased in Biological, Chemical and Industrial Applications

Beckman Coulter Life Sciences debuts a new family of innovative particle characterization products at Pittcon Conference and Expo, March 18-21, in Philadelphia, USA. DelsaMax particle analyzers measure the size and zeta potential of nanoparticles with groundbreaking speed and high precision.  Instruments in the family utilize two independent detection systems that operate in parallel – a unique and proprietary configuration that significantly streamlines workflows in biological, chemical, material and polymer science applications....

Workshops, Exhibit Complemented by Biomek 4000 Workstation Grant Contest

Labelled and Unlabelled Monoclonals Offer Specificity, Convenience, Flexibility

Beckman Coulter Life Sciences Introduces Flexible, Adaptable Kit

Certification Paves the Way for Genetic Testing of Patient Samples by Beckman Coulter Genomics

Beckman Coulter, Inc. has obtained a CLIA* Certificate of Registration, along with Massachusetts State Licensure, allowing Beckman Coulter Genomics to begin accepting clinical samples for genetic sequencing - the most technically complex CLIA category - and to provide those results to physicians for their use in treating, diagnosing and preventing disease in patients...